RNA Analysis Market by Product (Reagents, Instruments, Software), Technology (Microarrays, NGS, Sanger), Application (Clinical Diagnostics, Drug Discovery), End User (CROs, Hospitals) & Region - Global Forecasts to 2025
The global RNA analysis market is projected to reach USD 8.7 billion by 2025, at a CAGR of 13.9%. The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market.
The increasing focus on biomarker discovery and toxicogenomics, along with the increasing interest in outsourcing services, is expected to offer significant growth opportunities for the players operating in the global RNA analysis/transcriptomics market. On the other hand, the requirement of high capital investments and data management issues are expected to restrain the growth of this market to a certain extent.
To know about the assumptions considered for the study, Request for Free Sample Report
RNA Analysis Market Dynamics
Drivers: Increasing demand for personalized medicine
Personalized medicine, which has become a core area of research in the healthcare industry, has entered mainstream clinical practice and is changing how many diseases are identified, classified, and treated. These advancements are particularly evident in the area of oncology. According to the Personalized Medicine Coalition report (2017), the number of personalized drugs, treatments, and diagnostic products has increased since 2006, and this trend is expected to continue in the coming years.
Restraints: High capital investments
With the widespread implementation of novel applications, the use of transcriptomics research extends all the way from the discovery of novel drugs, vaccines, and diagnostic targets, toxicology, and identification of surrogate markers of activity in clinical research to the ability to provide information on the mechanisms of drug action. This requires the use of different types of platforms and instruments as well as laboratory documentation systems, contributing to the high cost of analytics.
Opportunities: Increasing focus on biomarker discovery
Biomarker identification, along with its clinical applications, has simplified drug discovery and development procedures in terms of evaluating the toxicity and efficacy of drugs. Besides, biomarkers for diseases like cancer, CVD, and neurological diseases are playing an integral role in enabling a better understanding of the disease pathway and progression.
The microarray technology used in transcriptomic analysis offers the promise of widespread study of diseases at the genomic level. It also aids in developing novel clinical biomarkers, identifying novel molecular abnormalities, and investigating drug efficacy.
Challenges: Lack of effective bioinformatics tools
Microarray experiments for transcriptomic studies produce enormous amounts of data. Therefore, researchers typically face problems in the interpretation of results and exploiting available computational power to process said data. Moreover, RNA sequencing data from transcriptomics studies have low genome coverage and high amplification bias, which makes data analysis extremely challenging, especially without effective bioinformatics tools. Many existing tools developed for bulk cell sequencing have not been effective in the analysis of transcriptomics data. This poses several challenges in terms of difficulties in calling copy number variations, identifying mutated genes in tumor samples, reconstructing cell lineages, recovering low abundant transcripts, and improving the accuracy of quantitative analysis of transcripts. Currently, there is a greater need from researchers for technical standards and bioinformatics software and databases to evaluate genome coverage and amplification bias, so that the results from different technologies can be compared with each other.
The reagents/consumables segment accounts for the largest share of the market, by product & service
Based on product & service, the RNA analysis/Transcriptomics market is segmented into reagents/consumables, instruments, software, and services. The reagents/consumables segment accounted for the larger market share in 2019. The increasing demand for high-quality reagents and the repeated use of media and reagents in transcriptome studies. Additionally, the growing R&D activities in the pharmaceutical industry, growing government investments in the field of life science research, and the increasing research being undertaken with integrated omics studies are contributing to the market for consumables.
The sequencing technologies segment is expected to grow at the highest CAGR during the forecast period
Based on technology, the RNA analysis/transcriptomics market is segmented into microarrays, PCR, sequencing technologies (Sanger sequencing and NGS technologies), and RNAi (gene silencing). The sequencing technologies segment is expected to witness the highest growth during the forecast period. RNA sequencing allows direct access to sequences of mRNA and is an equitable technology, which makes it more suitable for target identification and drug discovery applications. RNA sequencing also helps overcome several issues associated with microarrays, such as bias and variation due to hybridization and labeling efficiencies. Technological advancements in this segment are further set to drive market growth.
The drug discovery segment is expected to account for the largest share of the RNA analysis/transcriptomics market
The drug discovery segment accounted for the largest share of the market in 2019. This is attributed to the use of transcriptomics in drug discovery for target identification and validation, identification of efficacy and toxicity biomarkers from biological fluids, and investigation of drug action and toxicity mechanisms. The growing need to study a large number of genes to gain a better understanding of gene-to-drug interactions is further expected to drive the use of transcriptomic technologies in drug discovery applications.
CROs end-user segment is expected to grow at the highest CAGR in the RNA analysis/transcriptomics market during the forecast period
Based on end user, the RNA analysis/transcriptomics market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers, and contract research organizations. The contract research organizations (CROs) segment is expected to witness the highest growth during the forecast period. CROs provide affordable outlets for companies and academia to pursue new medicines and offer a cost-effective solution to developing drugs. They also support foundations, research institutions, and universities, in addition to government organizations, such as the NIH and EMA. These factors are driving the growth of this segment.
North America is expected to account for the largest share of the RNA analysis/transcriptomics market
In 2019, North America accounted for the largest share of the RNA analysis/transcriptomics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the increasing development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, high life science research funding, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies in North America. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment.
To know about the assumptions considered for the study, download the pdf brochure
RNA Analysis Market Key Players
The prominent players in this market are Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US).
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
2018–2025 |
|
Base year considered |
2019 |
|
Forecast period |
2020–2025 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Product, Technology, Application, End User |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa |
|
Companies covered |
Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Fluidigm Corporation (US), Eurofins Scientific (Germany), Sequentia Biotech SL (Spain), Acobiom (France), GenXPro GmbH (Germany), CD Genomics (US), Promega Corporation (US), Lexogen GmbH (Austria), Cenix BioScience GmbH (Germany), Takara Holdings, Inc. (Japan), bioMérieux SA (France), and LC Sciences LLC (US) |
The study categorizes the RNA Analysis/Transcriptomics Market based on product, technology, application, end user, and regional and global level.
By Product
- Reagents/Consumables
- Instruments
- Software
- Services
By Technology
- Microarrays
- Sequencing
- Polymerase Chain Reaction
- RNA Interference
By Application
- Clinical Diagnostics
- Drug Discovery
- Toxicogenomics
- Comparative Transcriptomics
By End User
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals
- Contract Research Organizations
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- Rest of Europe
-
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Recent Developments
- In 2020, Agilent Technologies launched its SureSelect XT HS2 RNA Reagent Kit.
- In 2020, Merck KGaA invested USD 21.32 million in a new Life Science Laboratory in Switzerland.
- In 2020, Agilent invested USD 150 million to expand its manufacturing capacity for nucleic acid-based therapeutics in Colorado, US.
- In 2019, Agilent and SomaLogic entered into an agreement wherein Agilent will supply customized high-fidelity oligo microarrays for use in the nucleic acid detection steps within SomaLogic's novel SOMAscan assay.
Frequently Asked Questions (FAQ):
Which are the top industry players in the global RNA analysis/transcriptomics market?
The top market players in the global RNA analysis/transcriptomics market include Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Fluidigm Corporation (US), Eurofins Scientific (Germany), Sequentia Biotech SL (Spain), Acobiom (France), GenXPro GmbH (Germany), CD Genomics (US), Promega Corporation (US), Lexogen GmbH (Austria), Cenix BioScience GmbH (Germany), Takara Holdings, Inc. (Japan), bioMérieux SA (France), and LC Sciences LLC (US).
Which global RNA analysis/transcriptomics products have been included in this report?
This report contains the following main segments:
- Reagents/Consumables
- Instruments
- Software
- Services
Which geographical region is dominating in the global RNA analysis/transcriptomics market?
The global RNA analysis/transcriptomics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is the largest regional market for RNA analysis/transcriptomics. The increasing development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, high life science research funding, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies in North America are driving the RNA analysis/ transcriptomics market in North America. The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the increasing investments by governments and industries, growing biotechnology research in APAC countries, and the rising awareness about personalized therapeutics.
Which is the leading global RNA analysis/transcriptomics technology?
The PCR segment accounted for the largest market share. PCR is the most suitable technique for interrogating a relatively small number of transcripts in a large set of samples. The increasing investments being made in the life science research and omics fields are also driving the adoption of the PCR technology for clinical diagnostics. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 20)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 RNA ANALYSIS/TRANSCRIPTOMICS MARKET
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 24)
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 SEGMENTAL SHARE ANALYSIS ILLUSTRATION
FIGURE 6 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 34)
FIGURE 8 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
FIGURE 10 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 11 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 12 GEOGRAPHIC ANALYSIS: RNA ANALYSIS/TRANSCRIPTOMICS MARKET
4 PREMIUM INSIGHTS (Page No. - 40)
4.1 RNA ANALYSIS/TRANSCRIPTOMICS MARKET OVERVIEW
FIGURE 13 INCREASING RESEARCH BEING CONDUCTED USING OMICS TECHNOLOGIES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY
FIGURE 14 PCR SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET IN 2019
4.3 RNA ANALYSIS/TRANSCRIPTOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 MARKET IN CHINA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
4.4 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY REGION (2018-2025)
FIGURE 16 NORTH AMERICA WILL CONTINUE TO DOMINATE THE RNA ANALYSIS/TRANSCRIPTOMICS MARKET UNTIL 2025
4.5 RNA ANALYSIS/TRANSCRIPTOMICS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 17 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 45)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 1 RNA ANALYSIS/TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing demand for personalized medicine
FIGURE 18 LAUNCH OF PERSONALIZED MEDICINE PRODUCTS, 2008-2016
5.2.1.2 Increasing pharmaceutical and biotechnology R&D expenditure and government funding
FIGURE 19 R&D INVESTMENTS, BY COUNTRY, 2017 VS. 2018 (USD BILLION)
5.2.1.3 Growing applications of RNA sequencing in transcriptomics
5.2.2 RESTRAINTS
5.2.2.1 High capital investments
5.2.3 OPPORTUNITIES
5.2.3.1 High growth opportunities in emerging markets
5.2.3.2 Increasing application of toxicogenomics
5.2.3.3 Increasing focus on biomarker discovery
5.2.3.4 Rising focus on outsourcing
5.2.4 CHALLENGES
5.2.4.1 Data management in transcriptomics research
5.2.4.2 Lack of effective bioinformatics tools
5.2.4.3 Dearth of skilled professionals
6 INDUSTRY INSIGHTS (Page No. - 53)
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INTEGRATION OF OMICS DATA IN BIOMEDICAL SCIENCES
6.2.2 GROWING FOCUS ON MONITORING POST-TRANSLATIONAL MODIFICATIONS
6.2.3 SHIFT FROM PLANT-BASED TO GENOME-BASED DRUG DISCOVERY
6.2.4 SPATIALLY RESOLVED TRANSCRIPTOMES
6.3 STRATEGIC BENCHMARKING
TABLE 2 PRODUCT PORTFOLIO ANALYSIS: RNA ANALYSIS/TRANSCRIPTOMICS MARKET
6.4 PORTER'S FIVE FORCES ANALYSIS
6.4.1 THREAT OF NEW ENTRANTS
6.4.2 THREAT OF SUBSTITUTES
6.4.3 BARGAINING POWER OF BUYERS
6.4.4 BARGAINING POWER OF SUPPLIERS
6.4.5 INTENSITY OF COMPETITIVE RIVALRY
6.5 RELATED MARKET ANALYSIS
6.6 COVID-19 IMPACT ON THE RNA ANALYSIS/TRANSCRIPTOMICS MARKET
7 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE (Page No. - 60)
7.1 INTRODUCTION
TABLE 3 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
7.2 REAGENTS/CONSUMABLES
7.2.1 REAGENTS/CONSUMABLES TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
TABLE 4 RNA ANALYSIS/TRANSCRIPTOMICS REAGENTS/CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
7.3 INSTRUMENTS
7.3.1 THE NEED FOR ACCURATE ANALYSIS IS DRIVING THE ADOPTION OF AUTOMATED INSTRUMENTS
TABLE 5 RNA ANALYSIS/TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
7.4 SOFTWARE
7.4.1 NEED FOR DATA MANAGEMENT AND QUALITY ENHANCEMENTS OF RESULTS OBTAINED MAKES SOFTWARE SOLUTIONS AN IMPERATIVE PART OF TRANSCRIPTOMICS
TABLE 6 RNA ANALYSIS/TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
7.5 SERVICES
7.5.1 INCREASING OUTSOURCING OF SERVICES TO PROPEL MARKET GROWTH
TABLE 7 RNA ANALYSIS/TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
8 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY (Page No. - 68)
8.1 INTRODUCTION
TABLE 8 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
8.2 POLYMERASE CHAIN REACTION
8.2.1 REAL-TIME PCR AIDS IN THE QUANTIFICATION OF LOW-COPY TRANSCRIPTS
TABLE 9 RNA ANALYSIS/TRANSCRIPTOMICS PCR MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
8.3 SEQUENCING
8.3.1 ADVANCES IN NGS MULTIPLEXING CAPABILITIES TO AID MARKET GROWTH
TABLE 10 RNA ANALYSIS/TRANSCRIPTOMICS SEQUENCING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
8.4 MICROARRAYS
8.4.1 WIDE ADOPTION OF MICROARRAYS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH
TABLE 11 RNA ANALYSIS/TRANSCRIPTOMICS MICROARRAYS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
8.5 RNA INTERFERENCE (GENE SILENCING)
8.5.1 TECHNOLOGICAL ADVANCEMENTS ARE SUPPORTING THE ADOPTION OF THIS TECHNIQUE FOR DIAGNOSTICS AND THERAPEUTICS
TABLE 12 RNA ANALYSIS/TRANSCRIPTOMICS RNA INTERFERENCE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
9 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION (Page No. - 75)
9.1 INTRODUCTION
TABLE 13 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
9.2 DRUG DISCOVERY
9.2.1 TARGETED SEQUENCING-BASED APPROACHES ARE GAINING MOMENTUM IN THE FIELD OF DRUG DISCOVERY
FIGURE 20 R&D INVESTMENTS IN LIFE SCIENCES, 2016-2018
TABLE 14 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2018-2025 (USD MILLION)
9.3 CLINICAL DIAGNOSTICS
9.3.1 TRANSCRIPTOMICS IS WIDELY ADOPTED FOR THE LARGE-SCALE GENE EXPRESSION PROFILING OF ONCOLOGICAL DISORDERS
TABLE 15 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2025 (USD MILLION)
9.4 TOXICOGENOMICS
9.4.1 INCREASING FOCUS ON ADR STUDIES IS DRIVING THE ADOPTION OF TRANSCRIPTOMICS FOR SYSTEMIC TOXICOLOGY
TABLE 16 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2018-2025 (USD MILLION)
9.5 COMPARATIVE TRANSCRIPTOMICS
9.5.1 TRANSCRIPTIONAL PROFILES ARE BEING WIDELY ADOPTED TO STUDY THE EVOLUTION AMONG SPECIES
TABLE 17 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2018-2025 (USD MILLION)
10 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER (Page No. - 84)
10.1 INTRODUCTION
TABLE 18 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.2.1 INCREASING INVESTMENTS FOR ONCOLOGY THERAPEUTICS DRIVING THE USE OF OMICS TECHNOLOGIES
TABLE 19 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
10.3 HOSPITALS & DIAGNOSTIC CENTERS
10.3.1 USE OF WHOLE-BLOOD TRANSCRIPTOME PROFILES FOR DISEASE DIAGNOSTICS IS AIDING MARKET GROWTH
TABLE 20 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2025 (USD MILLION)
10.4 ACADEMIC & RESEARCH INSTITUTES
10.4.1 GROWING GOVERNMENT INVESTMENTS TO PROPEL MARKET GROWTH
TABLE 21 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
10.5 CONTRACT RESEARCH ORGANIZATIONS
10.5.1 GROWING OUTSOURCING SERVICES BY PHARMACEUTICAL COMPANIES FOR FASTER DRUG DISCOVERY IS AIDING MARKET GROWTH
TABLE 22 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
11 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY REGION (Page No. - 92)
11.1 INTRODUCTION
FIGURE 21 RNA ANALYSIS/TRANSCRIPTOMICS MARKET: GEOGRAPHIC SNAPSHOT (2019)
TABLE 23 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY REGION, 2018-2025 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET SNAPSHOT
TABLE 24 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 25 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 26 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 27 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 28 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.2.1 US
11.2.1.1 The US dominates the North American market
TABLE 29 US: NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020 (USD BILLION)
TABLE 30 US: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 31 US: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 32 US: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 33 US: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Improving funding and infrastructure for omics-based research is supporting market growth
TABLE 34 CANADA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 35 CANADA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 36 CANADA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 37 CANADA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3 EUROPE
FIGURE 23 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET SNAPSHOT
TABLE 38 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 39 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 40 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 41 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 42 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Germany holds the largest share of the European market
TABLE 43 GERMANY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 44 GERMANY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 45 GERMANY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 46 GERMANY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.2 FRANCE
11.3.2.1 Increasing government support for omics-based research in the country to support market growth
TABLE 47 FRANCE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 48 FRANCE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 49 FRANCE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 50 FRANCE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.3 UK
11.3.3.1 Rising public and private funding for research to drive market growth
TABLE 51 UK: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 52 UK: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 53 UK: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 54 UK: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Growth in this market is driven by the improving R&D expenditure and disease diagnostics
TABLE 55 ITALY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 56 ITALY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 57 ITALY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 58 ITALY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.5 SWITZERLAND
11.3.5.1 Well-established pharmaceutical industry to drive market growth
TABLE 59 SWITZERLAND: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 60 SWITZERLAND: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 61 SWITZERLAND: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 62 SWITZERLAND: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Increasing collaborations for enhancing research to support market growth
TABLE 63 SPAIN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 64 SPAIN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 65 SPAIN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 66 SPAIN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 67 ROE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 68 ROE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 69 ROE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 70 ROE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET SNAPSHOT
TABLE 71 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 72 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 73 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 74 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 75 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.1 JAPAN
11.4.1.1 Early adoption of technologically advanced products to drive market growth
TABLE 76 JAPAN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 77 JAPAN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 78 JAPAN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 79 JAPAN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.2 CHINA
11.4.2.1 China is one of the fastest-growing markets offering significant growth opportunities
TABLE 80 CHINA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 81 CHINA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 82 CHINA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 83 CHINA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Increasing pharmaceutical R&D spending and government funding for research to drive market growth
TABLE 84 INDIA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 85 INDIA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 86 INDIA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 87 INDIA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.4 REST OF ASIA PACIFIC
TABLE 88 ROAPAC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 89 ROAPAC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 90 ROAPAC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 91 ROAPAC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 GROWTH IN THE PHARMACEUTICAL INDUSTRY IN MEXICO TO SUPPORT MARKET GROWTH
TABLE 92 LATIN AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 93 LATIN AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 94 LATIN AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 95 LATIN AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 IMPROVING FOCUS ON PRECISION MEDICINE AND DISEASE GENETICS IS DRIVING MARKET GROWTH
TABLE 96 MIDDLE EAST & AFRICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
TABLE 97 MIDDLE EAST & AFRICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 98 MIDDLE EAST & AFRICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 99 MIDDLE EAST & AFRICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 140)
12.1 OVERVIEW
FIGURE 25 PRODUCT LAUNCHES-KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM JANUARY 2017 TO OCTOBER 2020
12.2 MARKET SHARE ANALYSIS
FIGURE 26 NGS MARKET SHARE, BY KEY PLAYER, 2019
FIGURE 27 PCR MARKET SHARE, BY KEY PLAYER, 2019
12.3 COMPANY EVALUATION MATRIX
12.3.1 STARS
12.3.2 EMERGING LEADERS
12.3.3 PERVASIVE
12.3.4 EMERGING COMPANIES
FIGURE 28 RNA ANALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
12.4 COMPETITIVE SITUATION AND TRENDS
12.4.1 PRODUCT LAUNCHES
TABLE 100 PRODUCT LAUNCHES, 2017-2020
12.4.2 EXPANSIONS
TABLE 101 EXPANSIONS, 2017-2020
12.4.3 ACQUISITIONS
TABLE 102 ACQUISITIONS, 2017-2020
12.4.4 OTHER STRATEGIES
TABLE 103 OTHER STRATEGIES, 2017-2020
13 COMPANY PROFILES (Page No. - 149)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 THERMO FISHER SCIENTIFIC, INC.
FIGURE 29 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
13.2 AGILENT TECHNOLOGIES, INC.
FIGURE 30 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
13.3 BIO-RAD LABORATORIES, INC.
FIGURE 31 BIO-RAD LABORATORIES, INC: COMPANY SNAPSHOT (2019)
13.4 CD GENOMICS
13.5 PROMEGA CORPORATION
13.6 ILLUMINA, INC.
FIGURE 32 ILLUMINA, INC.: COMPANY SNAPSHOT (2019)
13.7 QIAGEN N.V.
FIGURE 33 QIAGEN N.V.: COMPANY SNAPSHOT (2019)
13.8 DANAHER CORPORATION
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
13.9 F. HOFFMANN-LA ROCHE LTD.
FIGURE 35 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2019)
13.10 MERCK KGAA
FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2019)
13.11 FLUIDIGM CORPORATION
FIGURE 37 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2019)
13.12 EUROFINS SCIENTIFIC
FIGURE 38 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
13.13 SEQUENTIA BIOTECH SL
13.14 ACOBIOM
13.15 GENXPRO GMBH
13.16 OTHER COMPANIES
13.16.1 LEXOGEN GMBH
13.16.2 CENIX BIOSCIENCE GMBH
13.16.3 TAKARA HOLDINGS, INC.
13.16.4 BIOMÉRIEUX SA
13.16.5 LC SCIENCES, LLC
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
14 APPENDIX (Page No. - 187)
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global RNA analysis/transcriptomics market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, manufacturing managers, and related key executives from various key companies and organizations operating in the global cleanroom technologies market. The primary sources from the demand side include purchase and sales managers, research organizations, and pharmaceutical and biotechnology companies.
Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and market dynamics.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product, technology, application, end-user, and region).
Data Triangulation
After arriving at the market size, the total RNA analysis/transcriptomics market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.
Objectives of the Study
- To define, describe, segment, and forecast the RNA analysis/transcriptomics market by product & service, technology, application, end user, and region
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall RNA analysis/transcriptomics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the RNA analysis/transcriptomics market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the RNA analysis/transcriptomics market and comprehensively analyze their core competencies2 and market shares
- To track and analyze competitive developments such as acquisitions; new product launches; expansions; collaborations, agreements, and partnerships; and R&D activities of the leading players in the RNA analysis/transcriptomics market
- To benchmark players within the RNA analysis/transcriptomics market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific RNA analysis/transcriptomics market into Australia, South Korea, New Zealand, and others
- Further breakdown of the Rest of Europe RNA analysis/transcriptomics market into the Netherlands, Denmark, and others
Generating Response ...
Growth opportunities and latent adjacency in RNA Analysis Market